Internal Medicine, Cardiovascular Disease · Newark, DE
NPI
1184604274
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
39 Omega Dr Bldg G
Newark, DE, 19713
Phone (302) 731-0001
Groups this clinician bills Medicare through
Medicare paid, 2024
$697K
8,631 services
Medicare patients, 2024
897
Average age 75
Drug cost, 2024
$2.7M
8,879 prescriptions
Company payments, 2025
$1,884
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony D Alfieri was code 99490 (chronic, principal, and transitional care management), 3,678 times for 411 patients. In total Anthony D Alfieri billed 8,631 services in 40 codes, and Medicare paid $697K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-23.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,678 | 411 | $46.75 | $172K |
| 99214 Office E&M - Established | Office | 1,106 | 562 | $86.29 | $95K |
| 93000 Electrocardiogram | Office | 562 | 404 | $9.76 | $5,487 |
| 99458 E&M - Miscellaneous | Office | 391 | 57 | $29.97 | $12K |
| 99457 E&M - Miscellaneous | Office | 376 | 59 | $37.38 | $14K |
| 93306 Echocardiography (TTE/TEE) | Office | 331 | 315 | $129.65 | $43K |
| 99454 E&M - Miscellaneous | Office | 313 | 46 | $35.70 | $11K |
| 93970 Duplex Scan - Extremity Veins | Office | 234 | 219 | $133.09 | $31K |
| 93971 Duplex Scan - Extremity Veins | Office | 228 | 96 | $87.95 | $20K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 225 | 57 | $4.79 | $1,077 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 131 | 71 | $36.54 | $4,787 |
| 99152 Anesthesia | Office | 115 | 70 | $38.22 | $4,395 |
| 99153 Anesthesia | Office | 110 | 67 | $8.86 | $975 |
| 36482 Varicose Vein Ablation | Office | 95 | 59 | $1,266.82 | $120K |
| 99204 Office E&M - New | Office | 94 | 94 | $107.15 | $10K |
By year: 2022 $819K for 10,233 services; 2023 $853K for 10,235 services; 2024 $697K for 8,631 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony D Alfieri prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,217 prescriptions and refills. In total Anthony D Alfieri wrote 8,879 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,217 | 3,438 | 377 | $30K |
| Carvedilol Generic | 502 | 1,371 | 154 | $8,484 |
| Atenolol Generic | 497 | 1,392 | 159 | $4,772 |
| Farxiga Dapagliflozin Propanediol | 407 | 981 | 132 | $527K |
| Amiodarone Hcl Generic | 353 | 993 | 117 | $7,368 |
| Xarelto Rivaroxaban | 351 | 787 | 108 | $424K |
| Atorvastatin Calcium Generic | 329 | 944 | 112 | $4,315 |
| Olmesartan Medoxomil Generic | 305 | 857 | 103 | $6,219 |
| Lisinopril Generic | 294 | 843 | 94 | $2,623 |
| Doxazosin Mesylate Generic | 286 | 797 | 85 | $6,790 |
| Entresto Sacubitril/Valsartan | 253 | 593 | 75 | $389K |
| Ezetimibe Generic | 205 | 593 | 65 | $9,064 |
| Amlodipine Besylate Generic | 197 | 558 | 66 | $2,318 |
| Jardiance Empagliflozin | 195 | 462 | 55 | $253K |
| Clopidogrel Clopidogrel Bisulfate | 194 | 544 | 65 | $2,792 |
Brand drugs: 2,144 claims; generic drugs: 6,735 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony D Alfieri $1,884 ($1,884 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novartis Pharmaceuticals Corporation with $268.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 23 | $268 |
| Merck Sharp & Dohme LLC MRK | 8 | $181 |
| Baxter Healthcare BAX | 4 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $155 |
| Axsome Therapeutics, Inc. AXSM | 11 | $137 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $108 |
| Boston Scientific Corporation BSX | 3 | $91.14 |
| Lilly USA, LLC LLY | 4 | $87.02 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $79.99 |
| BridgeBio Pharma, Inc. BBIO | 4 | $74.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.